RemeGen Co., Ltd.
REGMF
$1.50
-$0.54-26.47%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 210.55M | 193.39M | 172.67M | 151.24M | 136.65M |
| Total Other Revenue | 941.70K | 771.90K | 960.50K | 960.50K | 625.40K |
| Total Revenue | 211.49M | 194.16M | 173.63M | 152.20M | 137.27M |
| Cost of Revenue | 45.01M | 44.86M | 42.81M | 36.13M | 31.94M |
| Gross Profit | 166.48M | 149.30M | 130.82M | 116.07M | 105.33M |
| SG&A Expenses | 161.36M | 153.83M | 156.26M | 153.45M | 150.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.25M | -5.75M | -6.90M | -7.32M | -2.81M |
| Total Operating Expenses | 423.44M | 410.60M | 385.73M | 366.18M | 346.06M |
| Operating Income | -211.95M | -216.44M | -212.10M | -213.98M | -208.78M |
| Income Before Tax | -215.41M | -219.94M | -214.52M | -213.24M | -190.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -215.41 | -219.94 | -214.52 | -213.24 | -190.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -215.41M | -219.94M | -214.52M | -213.24M | -190.38M |
| EBIT | -211.95M | -216.44M | -212.10M | -213.98M | -208.78M |
| EBITDA | -186.42M | -192.64M | -190.11M | -193.45M | -189.85M |
| EPS Basic | -0.40 | -0.41 | -0.40 | -0.40 | -0.35 |
| Normalized Basic EPS | -0.25 | -0.26 | -0.25 | -0.25 | -0.23 |
| EPS Diluted | -0.40 | -0.41 | -0.40 | -0.40 | -0.35 |
| Normalized Diluted EPS | -0.25 | -0.26 | -0.25 | -0.25 | -0.23 |
| Average Basic Shares Outstanding | 2.16B | 2.15B | 2.16B | 2.16B | 2.18B |
| Average Diluted Shares Outstanding | 2.16B | 2.15B | 2.16B | 2.16B | 2.18B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -3.72% | -2.84% | -1.58% | -1.15% | -0.97% |
